Enter your email Address

Eyevensys Eyevensys Eyevensys Eyevensys
  • About
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • EYS606
  • Pipeline
    • Our Pipeline
    • EYS809
    • EYS611
  • News
    • Press Releases
    • In the Media
    • Events
    • Scientific Publications
  • Investors
  • Contact
Eyevensys

Nonviral Platforms Streamline Gene Therapy Delivery

  • September 1, 2023

Nonviral Platforms Streamline Gene Therapy Delivery

Nonviral Platforms Streamline Gene Therapy Delivery https://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg 150 150 Eyevensys Eyevensys https://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg September 1, 2023 September 14, 2023

In an article reviewing advancements in DNA plasmids, Eyevensys is featured with other innovative companies developing nonviral gene therapy.

Read More
Recent Posts
  • Nonviral Platforms Streamline Gene Therapy Delivery
  • Eyevensys Announces Positive Preclinical Data Demonstrating Superiority of EYS809 over Aflibercept for Wet Age-Related Macular Degeneration (AMD) at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
  • ARVO 2023: Eyevensys announces positive preclinical data demonstrating efficacy of EYS809 over aflibercept for wet AMD
  • Eyevensys Recaps Highlights from Investigator Meeting and Presentations at the ARVO 2022 Annual Conference   
  • Eyevensys to present at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting
Eyevensys Announces Positive Preclinical Data Demonstrating Superiority of EYS809 over Aflibercept for Wet Age-Related Macular Degeneration (AMD) at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

About Us
Meet the Team
Technology
Pipeline

Contact Us
Scientific Publications
Press Releases
Events

Cookie Policy
Privacy Policy

© 2023 Eyevensys. All rights reserved.

  • About
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • EYS606
  • Pipeline
    • Our Pipeline
    • EYS809
    • EYS611
  • News
    • Press Releases
    • In the Media
    • Events
    • Scientific Publications
  • Investors
  • Contact
Start Typing